Home
1 888 2 DONATE(1 888 236-6283)
CLINICSDONORSVOLUNTEERSHOSPITALSMEDIA ROOMABOUT USCAREERS
Find a Clinic:  search Search this site:  search
Clinic Search
Home > What Should I Know? > Safety and Testing
Why Should I Donate?
Who Needs Blood?
It's Easy...Here's How!
Can I donate?
Basic Eligibility
Donor Questionnaire
Malaria policy
Donation Date Calculator
American Sign Language
What Can I Donate?
Types of Donations
Blood
Plasma & Platelets
Stem Cells
Financial Gifts
Blood for Research
How Can I Get Involved?
In My Community
Send an e-card
Public Involvement
Volunteers
Partners for Life
What's Your Type
Ready, Set...Give!
OneMatch
Young Blood For Life
Holiday Promotion
What Should I Know?
Pandemic Preparedness
Safety and Testing
Research & Development
West Nile Virus (WNV)
Transfusion Related Acute Lung Injury (TRALI)
vCJD Travel Deferral
Blackboard
FAQs
Forms
Become a Volunteer
New Donor Form
Change Your Address
Join OneMatch
Become a Partner for Life Organization
Become a Partner for Life Member
Join Ready, Set... Give!
Donor Experience Survey
Hospitals
Customer Service
Circular of Information
Customer Letters
Plasma Protein Products
TransfusionMedicine.ca
Hospital Customer Forms
Resource Library
 

Chronology of events related to the MSM Policy

Year Event
Sept. 2009 Trial between Canadian Blood Services and Kyle Freeman will begin in the Superior Court of Ontario in Ottawa
Sept. 2008 CBS forms national LGBTTQ (lesbian-gay-bisexual-transgendered-two-spirited or queer) working group, whose mandate is to act as a resource for CBS to help educate on the issues and sensitivities of the LGBTTQ community while helping to promote the research agenda.
March 2008 CBS launches joint research opportunity with the Canadian Institute for Health Research focused on three areas; donor deferral strategies and the risk of blood-borne diseases, policy development and social aspects of blood system risk, and emerging pathogens in specific populations
June 2007 CBS Board defers pursuing a deferral change while launching research agenda to close the gaps in information identified through the consultations.
2006 CBS conducted its own epidemiological study of 40,000 donors to evaluate the proportion of donors with deferrable risks. The study was repeated in 2008 with results published internally.
2006 American Red Cross, America's Blood Centres and the AABB recommend to the FDA changing deferral to 1 year for MSM - FDA chose to uphold the indefinite ban stating it was the best way to keep the nation's blood supply safe.
2006 McLaughlin Centre for Population Health Risk Assessment commissioned to conduct risk assessment of MSM donor deferral criteria - did not make recommendations, put forward views for discussion at CBS Board of Directors.
2001 CBS implements nucleic acid amplification testing (NAT) for HIV - greatly reducing the "window period" where the virus is undetectable by test, but not eliminating it.
2001 CBS/Hema-Quebec co-sponsored international consensus conference on optimizing the donor selection process - no recommendation to change criteria due to not enough evidence to implement a change in deferral criteria
1988 Year that the current MSM deferral was introduced in blood screening by the Canadian Red Cross via filling out a written questionnaire , a formal consent and confidential unit exclusion form
1985 The first year thousands of Canadians were infected with HIV via tainted blood
1983 The first year a pamphlet was introduced to donors outlining the risk factors for HIV, with the hope that donors would self-exclude.
1977 The year 1977 has been identified as the date when rapid spread of HIV began throughout first world countries such as the United States and Canada.
Printer-friendly
Safety and Testing
Safety and Testing
The Screening Process
Testing
False Positive Results
Nucleic Acid Testing
Leukoreduction
Blood Safety

Top of the page Access to Information & Privacy Policies | Terms of Use | Copyright © 1998-2010 Canadian Blood Services. All rights reserved.